Back to Search
Start Over
Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
- Source :
-
Gut [Gut] 2012 Apr; Vol. 61 (4), pp. 507-13. Date of Electronic Publication: 2011 Sep 02. - Publication Year :
- 2012
-
Abstract
- Objective: A multicentre cohort follow-up study of a large number of patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma was conducted to elucidate the long-term outcome of the disease after Helicobacter pylori eradication.<br />Methods: 420 patients with gastric low-grade MALT lymphoma who had undergone successful H pylori eradication and been followed up for at least 3 years were registered from 21 participating institutes. Responders to treatment were defined as patients whose post-treatment biopsies showed complete histological response (ChR) or probable minimal residual disease (pMRD). Treatment failure was defined as the status of progressive disease or lymphoma relapse after ChR/pMRD.<br />Results: 323 patients (77%) responded to H pylori eradication. A logistic regression analysis showed that absence of H pylori, submucosal invasion determined by endoscopic ultrasonography and t(11;18)/API2-MALT1 were independent predictors of resistance to H pylori eradication. During the follow-up periods ranging from 3.0 to 14.6 years (mean 6.5 years, median 6.04 years), the disease relapsed in 10 of 323 responders (3.1%) while progressive disease was found in 27 of 97 non-responders (27%). Thus, 37 of 420 patients (8.8%) were regarded as treatment failures. Of these 37 patients, transformation into diffuse large B cell lymphoma occurred in nine patients. Among the non-responders and relapsed patients, 17 patients were subjected to a 'watch and wait' strategy while 90 patients underwent second-line treatments including radiotherapy (n=49), chemotherapy (n=26), surgical resection (n=6), chemoradiotherapy (n=5), antibiotic treatment (n=2), rituximab monotherapy (n=1) or endoscopic resection (n=1). Probabilities of freedom from treatment failure, overall survival and event-free survival after 10 years were 90%, 95% and 86%, respectively. Cox multivariate analysis revealed endoscopic non-superficial type to be an independent prognostic factor for adverse freedom from treatment failure, overall survival and event-free survival.<br />Conclusions: The excellent long-term outcome of gastric MALT lymphoma after H pylori eradication was confirmed by this large-scale follow-up study.
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents therapeutic use
Biopsy
Disease Progression
Drug Therapy, Combination
Epidemiologic Methods
Female
Helicobacter Infections complications
Humans
Japan
Lymphoma, B-Cell, Marginal Zone pathology
Lymphoma, B-Cell, Marginal Zone therapy
Male
Middle Aged
Neoplasm, Residual pathology
Prognosis
Proton Pump Inhibitors therapeutic use
Recurrence
Stomach Neoplasms pathology
Stomach Neoplasms therapy
Treatment Failure
Treatment Outcome
Young Adult
Helicobacter Infections drug therapy
Helicobacter pylori isolation & purification
Lymphoma, B-Cell, Marginal Zone microbiology
Stomach Neoplasms microbiology
Subjects
Details
- Language :
- English
- ISSN :
- 1468-3288
- Volume :
- 61
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Gut
- Publication Type :
- Academic Journal
- Accession number :
- 21890816
- Full Text :
- https://doi.org/10.1136/gutjnl-2011-300495